Das Produkt wurde korrekt in den Warenkorb gelegt.

discount label
H-FGRF-OH
3D-Ansicht

Biosynth logo

H-FGRF-OH

Ref. 3D-PP49918

1mg
172,00 €
10mg
196,00 €
100mg
303,00 €
Voraussichtliche Lieferung in Vereinigte Staaten, am Freitag 27. Dezember 2024

Produktinformation

Name:
H-FGRF-OH
Beschreibung:

Peptide H-FGRF-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-FGRF-OH include the following: Clinical manifestations and spermatogenesis outcomes in Chinese patients with congenital hypogonadotropic hypogonadism caused by inherited or de novo FGFR1 YF Yang, HL Ma, X Wang, M Nie, JF Mao - Asian Journal of , 2024 - journals.lww.comhttps://journals.lww.com/ajandrology/fulltext/9900/clinical_manifestations_and_spermatogenesis.151.aspx Myelin basic protein (MBP) and MBP peptides are mitogens for cultured astrocytes SA South, GE Deibler, SF Tzeng, A Badache - Glia, 2000 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/(SICI)1098-1136(20000101)29:1%3C81::AID-GLIA8%3E3.0.CO;2-O Natural Sourced inhibitors of EGFR, PDGFR, FGFR and VEGFRMediated signaling pathways as potential anticancer agents S Nandi, R Dey , A Samadder , A Saxena - Current Medicinal , 2022 - ingentaconnect.comhttps://www.ingentaconnect.com/content/ben/cmc/2022/00000029/00000002/art00005 Membrane-derived inhibitory factors P Datta - Tissue Growth Factors, 1981 - Springerhttps://link.springer.com/chapter/10.1007/978-3-642-67986-5_10 Reciprocal priming between receptor tyrosine kinases at recycling endosomes orchestrates cellular signalling outputs MP Smith , HR Ferguson, J Ferguson, E Zindy - The EMBO , 2021 - embopress.orghttps://www.embopress.org/doi/abs/10.15252/embj.2020107182 Density-dependent regulation of cell growth: an example of a cell-cell recognition phenomenon MA Lieberman, L Glaser - The Journal of membrane biology, 1981 - Springerhttps://link.springer.com/article/10.1007/BF01969440 FGFR as potential target in the treatment of squamous non small cell lung cancer M Tiseo, F Gelsomino, R Alfieri , A Cavazzoni - Cancer treatment , 2015 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0305737215000808 Rational discovery of small molecule inhibitor targeting invasion and tumor growth KS Kumar, C Brunner, M Schuster, L Kopp, A Gries - 2022 - researchsquare.comhttps://www.researchsquare.com/article/rs-1359115/latest Discovery of a small molecule ligand of FRS2 that inhibits invasion and tumor growth K Santhana Kumar, C Brunner, M Schuster, LL Kopp - Cellular Oncology, 2023 - Springerhttps://link.springer.com/article/10.1007/s13402-022-00753-x?trk=public_profile_project-button A STUDY OF GROWTH REGULATION IN 3T3 FIBROBLASTS (GLUCOSAMINIDASE, TUNICAMYCIN, GROWTH INHIBITORS) JM Hilfinger - 1984 - search.proquest.comhttps://search.proquest.com/openview/aa5eea212cd6adfbd1a5c7e0901566e0/1?pq-origsite=gscholar&cbl=18750&diss=y Novel"ruthenium cyclopentadienyl"-peptide conjugate complexes against human FGFR (+) breast cancer JF Machado , M Machuqueiro , F Marques - Dalton , 2020 - pubs.rsc.orghttps://pubs.rsc.org/en/content/articlehtml/2020/dt/d0dt00955e Biasing receptor tyrosine kinase signaling pathways J Watson, BJ Arey, A Alt - Biased Signaling in Physiology, Pharmacology , 2014 - Elsevierhttps://www.sciencedirect.com/science/article/pii/B9780124114609000057 Tissue microarray-based studies of patients with lymph node negative breast carcinoma show that met expression is associated with worse outcome but is not I Tolgay Ocal, M Dolled-Filhart - Journal of the , 2003 - Wiley Online Libraryhttps://acsjournals.onlinelibrary.wiley.com/doi/abs/10.1002/cncr.11335 The substrate as a skeleton: ground reaction forces from a soft-bodied legged animal HT Lin , BA Trimmer - Journal of Experimental Biology, 2010 - journals.biologists.comhttps://journals.biologists.com/jeb/article-abstract/213/7/1133/10142 Antiangiogenic heparin-derived heparan sulfate mimics B Casu, A Naggi - Pure and applied chemistry, 2003 - degruyter.comhttps://www.degruyter.com/document/doi/10.1351/pac200375020157/html Molecular docking study on the potency of glycosaminoglycans (GaGs) as co-activators of fibroblasts proliferation and differentiation A Neamtu , M Neamtu , T Petreus - of Experimental and , 2010 - researchgate.nethttps://www.researchgate.net/profile/Andrei-Neamtu/publication/267783007_Molecular_docking_study_on_the_potency_of_glycosaminoglycans_GaGs_as_co-activators_of_fibroblasts_proliferation_and_differentiation/links/54c4b2910cf256ed5a955fe0/Molecular-docking-study-on-the-potency-of-glycosaminoglycans-GaGs-as-co-activators-of-fibroblasts-proliferation-and-differentiation.pdf Association of syndecan-1 with angiogenesis-related markers, extracellular matrix components, and clinicopathological features in colorectal carcinoma A Mitselou , U Skoufi, KE Tsimogiannis - Anticancer , 2012 - ar.iiarjournals.orghttps://ar.iiarjournals.org/content/32/9/3977.short

Hinweis:
Unsere Produkte sind nur für Laborzwecke. Für jede andere Verwendung, bitte melden sie sich bei uns.
Marke:
Biosynth
Langzeitlagerung:
Hinweise:

Chemische Eigenschaften

Molekulargewicht:
525.61 g/mol
MDL:
Schmelzpunkt:
Siedepunkt:
Flammpunkt:
Dichte:
Konzentration:
EINECS:
Merck:
HS-Code:

Gefahrenhinweise

UN-Nummer:
EQ:
Klasse:
H-Sätze:
P-Sätze:
Flugverbot:
Gefahrenhinweis:
Verpackungsgruppe:
LQ:

Technische Anfrage zu: 3D-PP49918 H-FGRF-OH

Bitte verwenden Sie stattdessen den Warenkorb, um ein Angebot oder eine Bestellung anzufordern

Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.

* Obligatorische felder
Willkommen bei CymitQuimica!Wir verwenden Cookies, um Ihren Besuch zu verbessern. Wir schließen Werbung nicht ein.

Bitte beachten Sie unsere Cookie-Richtlinie  für weitere Details oder passen Sie Ihre Einstellungen unter “Konfigurieren” an.